← FDA Drug Approvals (Drugs@FDA)

ILARIS

BLA · Biologics License Application · Sponsor: NOVARTIS PHARMS · Approved 2009-06-17

Drug application

FDA Application #
BLA125319
Application type
Biologics License Application
Brand name
ILARIS
Generic name
CANAKINUMAB
Active ingredients
CANAKINUMAB
Dosage form
INJECTABLE
Route
SUBCUTANEOUS
Marketing status
Prescription
Sponsor
NOVARTIS PHARMS
Manufacturer
Novartis Pharmaceuticals Corporation
First approval
2009-06-17

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown